WHAT'S WRONG WITH AMERICA'S HEALTHCARE SYSTEM

The National Cancer Institute (NCI) steadfastly refused to test the Koch therapy, or the Hoxsey therapy, or Krebiozen, but did test hydrazine sulfate (HS), a very cheap non-toxic chemical which cured many terminal patients after conventional therapy had failed to do so. It might have been better if NCI had not tested hydrazine sulfate, for it cheated in the trials. Dr. Joseph Gold, the chief proponent of HS, has warned for years that certain substances - alcohol, tranquilizers, and barbiturates - were incompatible with HS and would cancel its effect - or even make a harmful combination with it. In the Soviet Union and in four trials within the U.S., Dr. Gold's warnings were scrupulously observed, and the average results were 40-50% success in terminal cancer patients - people got better. However, the NCI maintained that the "incompatibles" were a "non-issue" and gave barbiturates to 94% of the 600 patients it treated with HS from 1989 to 1993. Instead of a 40-50% recovery, there were more survivors of the Titanic than

there were of the NCI's trials, where no one got better, all died. Penthouse magazine blew the whistle on the scandal and suggested that the families of the deceased patients should sue the NCI for genocide. As a cancer treatment, hydrazine sulfate costs about 60 cents a day. Dr. Gold estimates that the cost of one session of chemotherapy would pay for a year's supply of HS (Chapter 10).

Chapter 7 on colostrum (a mother's first milk) tells how former Congressman Berkley Bedell of Iowa was cured of Lyme disease, after antibiotics proved ineffective, by a colostrum "targeted" against the spirochete which causes Lyme disease. This was achieved by injecting a killed lyme spirochete into the udder of a cow three weeks before her calf was born. The cow's colostrum then contained antibodies against the lyme spirochete, and this cured the Congressman. There is no known limit to what can be produced by the targeted colostrum method; it presumably could provide a cure for TB, or for various bacteria - even protection against anthrax. It has been used successfully against cancer in animals. The NCI and the NIH have shown no interest in this method, and the FDA discourages the private sector from developing it. When a colostrum drink was shown to be effective against arthritis, the FDA squelched it. The trial of the Minnesota farmer who helped Congressman Bedell to recover is described.

In fact, there is a trial in almost every chapter of the book, as the stories tell what befell the protagonists of various non-toxic, non-pharmaceutical therapies.

The lessons of the ten stories show that there are two principal impediments to non-toxic health breakthroughs: 1) the FDA, and 2) doctors' fear of losing their licenses for using unapproved medicines. There are two simple solutions: 1) remove the FDA's regulatory authority over anything no more toxic than aspirin (everything in this book would pass that test) and 2) pass the Access to Medical Treatment Act, which is already introduced in both houses of Congress. This bill was conceived by Congressman Berkley Bedell so that all Americans might have access to the sorts of unconventional therapies which he believes saved his life twice; Lyme disease, as noted, and then from a threatened recurrence of prostate cancer, described in Chapter 8. The "Access" Act provides a procedure for putting on the market medicines not approved by the FDA and protects from prosecution doctors who use them. Doctors would need to obtain the "informed consent" of a patient, who signs a statement that he/she realizes the treatment to be given is not approved by the FDA.

Had these two changes been the law of the land, this book would not have been written, for the stories that follow would not have happened. Legislating these two simple changes would permit the return of most of the therapies described except for those which have been lost. Since all were inexpensive, with their return and the appearance of other breakthroughs waiting in the wings, the costs of American healthcare would plummet.